Skip to main content

In this Issue:

Data, Privacy & Cybersecurity | Antitrust | Foreign Investment | Corporate | Compliance | Medical Treatment & Health


Data, Privacy & Cybersecurity

TC260 seeks comments on draft Information security technology —Security requirements of vehicle collected data

信安标委就《信息安全技术 汽车采集数据的安全要求》征求意见 

CAC seeks comments on draft Measures for Data Export Security Assessments

国家网信办就《数据出境安全评估办法》征求意见

The MIIT solicits comments on the Measures on the Administration of Data Security in the Industry and Information Technology Sector (Trial)

工信部就《工业和信息化领域数据安全管理办法(试行)》征求意见

The NISSTC seeks comments on the draft Practical Guide to Cybersecurity Standards – Guide to Data Classification and Grading

信安标委就数据分类分级指引征求意见,108

Antitrust

The Standing Committee of the 13th National People's Congress Seeks Public Comments on the Anti-Monopoly Law (Draft Amendments)

全国人大常委会就《反垄断法》修正草案征求意见

SAMR releases Guidelines for the Overseas Anti-monopoly Compliance of Enterprises

国家市场监督管理总局发布《企业境外反垄断合规指引》

Foreign Investment

NDRC and MOFCOM issue updated 2021 Negative List and 2021 FTZ Negative List

国家发改委和商务部发布《外商投资准入特别管理措施(负面清单)(2021年版)》及《自由贸易试验区外商投资准入特别管理措施(负面清单)(2021年版)》 

Corporate

The Standing Committee of the 13th National People's Congress Seeks Public Comment on the Amendment to Company Law of the People’s Republic of China

全国人大常委会就《中华人民共和国公司法(修订草案)》征求意见

Compliance

The National Development and Reform Commission Seeks Public Comments on the Negative List for Market Access (2021 Version)

国家发改委就《市场准入负面清单(2021年版)》征求意

SAMR and MOF jointly release Interim Measures for Rewards for Whistleblower Reports of Major Violations in the Field of Market Regulation

场监管总局等两部门联合印发《市场监管领域重大违法行为举报奖励暂行办法》

CNIPA issues General Trademark Violation Judgment Standards

国家知识产权局印发《商标一般违法判断标准》

Medical Treatment & Health

The National Health Commission Seeks Public Comments on the Rules for Regulation of Internet-based Diagnosis and Medical Treatment

国家卫健委就《互联网诊疗监管细则》征求意见

The National Medical Products Administration Releases the Pharmacovigilance Quality Management Specifications

国家药监局发布《药物警戒质量管理规范》

* This GT Newsletter is limited to non-U.S. matters and law.

Continue reading the full GT China Newsletter | Winter 2021 (Issue 53).

Read previous issues of GT’s China Newsletter.